Innovation and imitation,opportunit®♣ y and challenge
Asia-Pacific Pharma IP Leader summit2019---14th∑π≥≈-15th NOV, Beijing CHINAOn March 19↔±≠☆, 2019, the World Intellectual Pro§₩♦perty Organization (WIPO) published its global i₽ntellectual property report 2018.Asia₹&δ&n innovators filed more than half of theiγ♦≤♦r international patent applica↕λtions through WIPO for the ¶≠first time in 2018, w←§ith significant growth in China, India and South ™₽§Korea, the report noted. As a teφ↑§→chnology-intensive industry, phaδ≈ rmaceutical industry attaches great importance≈₽≠™ to patent application and intellectu ↓al property protection.≤εε✔In recent years, the size of the global ph∏£∏armaceutical market has maintained a¶γ₽' steady growth, with China, Sou≠↑♣∏th Korea, India and other emerg•↓Ω♠ing markets presenting a rapid g≈§rowth momentum. Due to the diφ↑φ↓fferent intellectual property policies ♦→≥©of different countries, the strategic layout of €₹¶→global intellectual property, the differenceλ↓§ s of pharmaceutical inte∏ llectual property policies of Asia-pacific coun¶§©tries, the patent review process±✘, litigation procedures and Generic drug paβ™tent strategy have gradually becom¥"e the hot spots of the pharmaceutical inte€÷λllectual property industry.In this context, →£σthe 2019 Asia-pacific Pharmaceutical ≠ε"IP Leader Summit will be held in ₽×Beijing on November 14-15, and ∞±will attract more than 500 industry experts fr£₹®om domestic and foreign pharmaceutical com&πpanies, biotechnology co¥©✘±mpanies, governments, associations, law firδ≠>ms, intellectual property agents $÷↓ and other companies to attend.Agenda Fr ✘↔amework:Section 1:Interpreta"±tion of Policy: Development of Pharmaceutical IP ±Ωunder the New Legislaε≤←±tive Landscape Section 2:Pharmaceutical R&D I↓→®nnovation and IP Protection -- Global V≈<<isionSection 3:Case Sharing★× of Pharmaceutical Patε☆÷→ent Invalidity, Infringe××ment, LitigationSection 4:Oppor÷→♥←tunities and challengeβ>↕™s for generics companies under the new sitλ<δuation HOTSPOT:ü Medical Poli₽γcy Interpretation under the Bacσλ•kground of Patent Law>♦♠ Amendmentü The i •nnovation of Judicial Mec≤±☆≈hanism Promotes the Developmeε♠™¶nt of Pharmaceutical In✔÷♥tellectual Propertyü&♦₩↑φnbsp; Intellectual Property Management Exper αγience in Multinational Pharmaceutical Compa<∞£←nies, Patent Layout Strategy, Litigation Stra¶→≠ tegyü he Data P"φ"rotection Regulations of Drug Test—New Eraü&nb∏™π♥sp; Trade Secrets and ε≥Patent Layout in the M✔↕π∏edical Fieldü Es☆∑tablishing The Internal Intellectual Proper→<$ty System under The New Legisla÷♣δtive Landscapeü Opportunities aδ↕≤®nd Challenges of Pharmaceutical Enterpε♣"®rises under Patent Term Compensation System-ε±-- Global Vision and Its Implications for ±×∑>Chinaü Latest Changes in European Patent ' ♥Application and Review ←≈<Proceduresü Analysis o♣'f Hot Cases of Recent Patent Invalidationü ¶↕ The Procedure of American Pharmaceutical Patent ♥litigation and its Enlightenment toα$ ✔ Chinese Pharmaceutical Enterprises&nb>≈•≥sp; ü Appli←€cation techniques and pr≠•×otection strategies fπ€α÷or European and American biomedical γ≠×patentsü Changes in standards for cre♥₩≠↓ative review of patentsü European, Amer♥γ♦ican and Japanese Medical Patent Examination±♦α∏ Cases and its implications for DomesticPhar÷↑'maceutical Companiesü Recent Ω✘♦Hot Patent Infringement Cases Analys'™isü The Strateδ™ gy of Indian Generic Drug Companies in R&↓✔ D and Pre-PAü How to avoid the Pate<♣nt Trap in Generic Drug Developmentü Theε♣π Strategy of Genericα₽≤≥ Drug Companies to Enter the European$ ✘ and American Marketsü Patentabiε™↕Ωlity in Europe, the United State♥"πs and Chinaü Patent litigation in Euσ₽φ♠ropeü Doubts aro↑™€®und the Unified Pate>βε↔nt Court (UPC) agreement an¥↓$©d Brexitü Second medicalφ use patentsComposition of participants: ∑φ™; Summit highlights:1σ←0+ Hot topic20+ ↓∑≠∏Authoritative speech5 0+ Industry media4 0∏ε+ BIC110+pharma com§↓βpany 500+專業(yè)參會(huì)嘉賓  ÷©; >←©✔ Profe∑≈ssional participantsOfficial registration and conσ ®↓sultation channels:Contact:AnnPhone: 021-65650305✔'Email:Marketing@zenseegroup.comhttp:λ÷→∏//en.zenseegroup.com/p/510934/